(:IDNG)
Business Focus: N/A
Oct 16, 2019 08:00 am ET
RedHawk Reports Fiscal Year 2019 Results
LAFAYETTE, Louisiana, Oct. 16, 2019 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company") a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial services, announced today financial results for the fiscal year 2019, ended June 30, 2019.
Sep 13, 2019 01:00 pm ET
RedHawk Announces Appointment of Senior Medical Device Sales Executive to Board
LAFAYETTE, LA / ACCESSWIRE / September 13, 2019 / RedHawk Holdings Corp. (OTC PINK:SNDD) (“RedHawk” or the “Company”) announced today that seasoned medical device sales and marketing veteran, Gerald (“Jerry”) C. Guzzino, has been appointed to its board of directors effective October 15, 2019. Mr. Guzzino has more than 20 years of experience in medical device sales and marketing and is an accomplished, growth-oriented executive.
Sep 11, 2019 01:00 pm ET
RedHawk Announces New Trading Name and Trading Symbol
Trading to begin on September 12, 2019 under trading name “RedHawk Holdings Corp.” and new trading symbol “SNDD”
May 10, 2019 08:00 am ET
RedHawk Expands Sandd Sales Infrastructure
LAFAYETTE, LA / ACCESSWIRE / May 10, 2019 / RedHawk Holdings Corp. (OTC PINK: IDNG) ("RedHawk" or the "Company") announced today that it has entered into a customer-specific sales representation agreement with Jeeds Health, Inc., an affiliate of Pharmaceutical Buyers, Inc. ( "PBI" - www.pharmaceuticalbuyersinc.com ), for the sale of its SANDD mini ("Sharps and Needle Destruction Device") needle destruction devices. The Company believes the agreement will eventually extend
Oct 04, 2018 09:30 am ET
REDHAWK ACQUIRES NEEDLE DESTRUCTION TECHNOLOGY
RedHawk Holdings Corp. (OTC: IDNG) (“RedHawk” or the “Company”) announced today that RedHawk Medical Products, LLC, a wholly-owned subsidiary of the Company, has acquired the world-wide exclusive manufacturing and distribution rights to certain...
Dec 13, 2017 03:00 pm ET
RedHawk Initiates Plan to Eliminate Debt
Transaction Continues Company Goal to Restructure its Balance Sheet Without Dilution
Dec 11, 2017 12:26 pm ET
RedHawk Completes EcoGen Share Transfer Agreement
LAFAYETTE, La., Dec. 11, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that along with its wholly-owned subsidiary, RedHawk Pharma UK Limited (“RedHawk Pharma”), it has completed the previously announced share transfer...
Nov 22, 2017 04:30 pm ET
RedHawk Announces First Quarter Results
RedHawk Updates EcoGen Settlement, Announces Organizational Additions
Nov 01, 2017 09:00 am ET
RedHawk Reports Year End Results
LAFAYETTE, La., Nov. 01, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today a consolidated net loss of $407,681 on revenues of $1,670,488 (net revenues of $929,859) for the twelve month period ended June 30, 2017. The 2017 fiscal year end results include approximately $300,000 of non-recurring litigation and transactional costs. The June 30, 2017 fiscal year end results compare to a consolidated net loss of $1,267,960 on minimal revenues for the comparable twelve month period ended June 30, 2016. The net loss for the fiscal year ended Ju...
Nov 01, 2017 09:00 am ET
RedHawk Reports Year End Results
LAFAYETTE, La., Nov. 01, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today a consolidated net loss of $407,681 on revenues of $1,670,488 (net revenues of $929,859) for the twelve month period ended...
Sep 18, 2017 01:00 pm ET
RedHawk Pharma Agrees to Complete Marketing and Operational Joint Venture Agreement
LAFAYETTE, La., Sept. 18, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that RedHawk Pharma UK Ltd (“RedHawk Pharma”), a wholly-owned subsidiary of RedHawk, has agreed in principle to enter into definitive marketing and operational joint venture agreements (“Joint Venture Agreements”) with ICE Pharma Group (“IPG”), a United Kingdom-based generic pharmaceutical sales and compliance company. IPG is led by David K. Bilton, a pharmaceutical healthcare veteran with 35 years of experience in global strategic procurement, supply chain mana...
Mar 13, 2017 04:00 pm ET
RedHawk Announces Second Quarter Results
YOUNGSVILLE, La., March 13, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today a consolidated net loss of $282,027 ($nil per share) on gross revenues of $718,337 for the three month period ended December 31, 2016. Excluding a non-recurring gain of $156,697, the Company reported a net loss of $291,810 ($nil per share) on minimal revenues for the comparable three month period ended December 31, 2015....
Jan 31, 2017 04:00 pm ET
RedHawk Sues Former Executive
YOUNGSVILLE, La., Jan. 31, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today it has joined with Beechwood Properties, LLC (“Beechwood”) in a lawsuit (“Lawsuit”) filed in the United States District Court for the Eastern District of Louisiana (2:17-cv-00819) against Daniel J. Schreiber (“Schreiber”), a former Company executive, and the Schreiber Living Trust dated February 8, 1995 (collectively referred to herein as the “Defendants”). The Lawsuit alleges the Defendants acquired 57,064,608 shares of Company’s common stock through securit...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.